PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.\', \'Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.\', \'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.\', \'Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.\', \'Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.\', \'Vir Biotechnology, San Francisco, CA 94158, USA.\', \'Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.\', \'Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.\', \'Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abm8143
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 34990214
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all